New Men B immunisation advice

Following recent high profile stories about child deaths from meningitis B, Public Health England has issued further advice:

Men B immunisation programme

Following recent media coverage about the death of a young girl from invasive meningococcal disease caused by Men B, many GP practices have had queries from parents about the availability of Men B immunisation. 

This information is taken from Public Health England publications and the GOV.UK website (see below for details).

What is the national policy for Men B immunisation?

The Men B immunisation programme started on 1 September 2015 for babies aged 2 months, ie, babies born on or after 1 July 2015.  There was a limited catch-up programme for babies born on or after 1 May 2015.  The routine schedule is for immunisation to be given at 2 and 4 months with the primaries, with a booster at 12 months.

Can I vaccinate children born before 1 May 2015 if parents request it? 

No. The national stock of Bexsero® should only be used to vaccinate children who are eligible for NHS vaccination.

Can I vaccinate children born on or after 1 May 2015 who have not yet been vaccinated?

Yes.  All children in the eligible cohort (ie, born on or after 1 May 2015) remain eligible for Men B immunisation until the age of two years. When Bexsero® has not been given as part of a primary course, give two doses at least two months apart. Those children who have received one dose before their first birthday only require one more dose. Please see the MenB PGD for more information.

If parents ask to pay for Men B immunisation for their children, what should I tell them?

GPs should not charge their own patients (ie, those registered at their practice) a private fee for the vaccine.

Parents seeking the vaccine privately should be made aware that they will be liable for the full costs of the vaccine and any additional administration charges that the private provider may apply. We understand that GSK has supply constraints on the Bexsero vaccine for the private market. Practices must not use centrally-procured stock for the national programme to vaccinate private patients or any patients outside the eligible cohort (other than those at high risk as defined in the green book).

Further information

Last updated : 16 Mar 2016

 

Mword 31 - We have your backs (01 Dec 2016)

1 December...
Read more »

Meeting with David Burrowes MP (24 Nov 2016)

On 4 November Dr Michelle Drage met David Burrowes, the Conservative MP for Enfield Southgate, at the Gillan House Surgery in his constituency. They were joined by Dr Vicky Weeks,...
Read more »

Health Select Committee winter pressure report endorses community general practice model (24 Nov 2016)

On 3 November the Health Select Committee released its report Winter pressure in accident and emergency departments. The main findings reflect our concerns that lack of support for community...
Read more »

PCSE Performers List problems and alternative arrangements (24 Nov 2016)

All GP trainees, newly qualified GPs and GPs applying to join the Medical Performers’ List should be aware of the following issues: GPs are not lawfully allowed to perform any...
Read more »

New GPC Co-Commissioning Guidance (24 Nov 2016)

The BMA General Practitioners Committee have issued a guidance update for GP practices and LMCs in England about options for Clinical Commissioning Groups (CCGs) to take greater commissioning control (“co-commissioning”),...
Read more »

2016 Autumn Statement and Dr Michelle Drage's response (24 Nov 2016)

Yesterday (Wednesday) Chancellor, Rt Hon Philip Hammond MP, delivered his first, and last, Autumn Statement. From 2017 there will be a Spring statement responding the Spring OBR report and an...
Read more »

Our November 2016 workforce survey is now live (24 Nov 2016)

Thank you in advance for making space in your hectic day to complete our short survey on practice workforce issues which will help us to gather insight to share with...
Read more »

Patient participation workshops starting in the New Year (24 Nov 2016)

Our Patient Engagement project has been working with practices and patient participation group (PPG) members to identify the benefits and challenges involved in developing active and effective PPGs. As a...
Read more »
Next Page »
« Previous Page